Information Collection: NRC Request for Sodium Iodide I-131 Treatment and Patient Release Information, 35990-35991 [2015-15391]

Download as PDF 35990 Federal Register / Vol. 80, No. 120 / Tuesday, June 23, 2015 / Notices Federal Register on October 22, 2003 (68 FR 60422). The licensee affirmed the applicability of the model NSHC determination in its application dated July 24, 2014. Date of issuance: May 28, 2015. Effective date: As of the date of issuance and shall be implemented within 60 days of issuance. Amendment No.: 99. A publiclyavailable version is in ADAMS under Accession No. ML15092A761; documents related to this amendment are listed in the Safety Evaluation enclosed with the amendment. Facility Operating License No. NPF– 90: Amendment revised the Facility Operating License and Technical Specifications. Date of initial notice in Federal Register: September 30, 2014 (79 FR 58827). The Commission’s related evaluation of the amendment is contained in a Safety Evaluation dated May 28, 2015. NSHC determination comments received: No. Dated at Rockville, Maryland, this 12th day of June 2015. For the Nuclear Regulatory Commission. A. Louise Lund, Acting Director, Division of Operating Reactor Licensing, Office of Nuclear Reactor Regulation. [FR Doc. 2015–15275 Filed 6–22–15; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [NRC–2015–0020] Information Collection: NRC Request for Sodium Iodide I–131 Treatment and Patient Release Information Nuclear Regulatory Commission. ACTION: Notice of submission to the Office of Management and Budget; request for comment. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) has recently submitted a proposed collection of information to the Office of Management and Budget (OMB) for review. The information collection is entitled, ‘‘NRC Request for Sodium Iodide I–131 Treatment and Patient Release Practices.’’ DATES: Submit comments by July 23, 2015. mstockstill on DSK4VPTVN1PROD with NOTICES SUMMARY: Submit comments directly to the OMB reviewer at: Vlad Dorjets, Desk Officer, Office of Information and Regulatory Affairs, (3150–XXXX), NEOB–10202, Office of Management ADDRESSES: VerDate Sep<11>2014 18:39 Jun 22, 2015 Jkt 235001 and Budget, Washington, DC 20503; telephone: 202–395–7315, email: Vladik_Dorjets@omb.eop.gov. FOR FURTHER INFORMATION CONTACT: Tremaine Donnell, NRC Clearance Officer, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001; telephone: 301–415–6258; email: INFOCOLLECTS.Resource@nrc.gov. SUPPLEMENTARY INFORMATION: I. Obtaining Information and Submitting Comments A. Obtaining Information Please refer to Docket ID NRC 2015– 0020 when contacting the NRC about the availability of information for this action. You may obtain publiclyavailable information related to this action by any of the following methods: • Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC 2015–0020. A copy of the collection of information and related instructions may be obtained without charge by accessing Docket ID NRC 2015–0020 on this Web site. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. The supporting statement and Patient Release Federal Register Notice (FRN) Soliciting Information is available in ADAMS under Accession No. ML15134A123. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. • NRC’s Clearance Officer: A copy of the collection of information and related instructions may be obtained without charge by contacting the NRC’s Clearance Officer, Tremaine Donnell, Office of Information Services, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415–6258; email: INFOCOLLECTS.Resource@NRC.GOV. B. Submitting Comments The NRC cautions you not to include identifying or contact information that you do not want to be publicly disclosed in your comment submission. The NRC posts all comment PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 submissions at https:// www.regulations.gov as well as entering the comment submissions into ADAMS. The NRC does not routinely edit comment submissions to remove identifying or contact information. If you are requesting or aggregating comments from other persons for submission to the NRC, then you should inform those persons not to include identifying or contact information that they do not want to be publicly disclosed in their comment submission. Your request should state that the NRC does not routinely edit comment submissions to remove such information before making the comment submissions available to the public or entering the comment submissions into ADAMS. II. Background Under the provisions of the Paperwork Reduction Act of 1995 (44 U.S.C. chapter 35), the NRC recently submitted a proposed collection of information to OMB for review entitled, ‘‘NRC Request for Sodium Iodide I–131 Treatment and Patient Release Practices.’’ The NRC hereby informs potential respondents that an agency may not conduct or sponsor, and that a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The NRC published an FRN with a 60day comment period on this information collection on March 3, 2015; 80 FR 11471, entitled ‘‘NRC Request for Sodium Iodide I–131 Treatment and Patient Release Practices.’’ 1. The title of the information collection: ‘‘NRC Request for Sodium Iodide I–131 Treatment and Patient Release Practices.’’ 2. OMB approval number: An OMB control number has not yet been assigned to this proposed information collection. 3. Type of submission: New. 4. The form number if applicable: Not Applicable. 5. How often the collection is required or requested: Once. 6. Who will be required or asked to respond: Medical professional organizations, physicians, patients, patient advocacy groups, NRC and Agreement State medical use licensees, Agreement States, and other interested individuals who use, receive, license or have interest in the use of I–131 sodium iodide (hereafter referred to as ‘‘I–131’’) for the treatment of thyroid conditions. E:\FR\FM\23JNN1.SGM 23JNN1 Federal Register / Vol. 80, No. 120 / Tuesday, June 23, 2015 / Notices mstockstill on DSK4VPTVN1PROD with NOTICES 7. The estimated number of annual responses: A one-time collection estimated to have 1,180 responses (620 medical community + 560 patients). 8. The estimated number of annual respondents: 1,180 respondents (620 medical community + 560 patients). 9. An estimate of the total number of hours needed annually to comply with the information collection requirement or request: 457.5 hours (255 medical community + 202.5 patients). 10. Abstract: The NRC is requesting a one-time information collection that will be solicited in an FRN. The FRN will have specific I–131 patient release questions associated with: (1) Existing Web sites that the responders believe provide access to clear and consistent patient information about I–131 treatment processes and procedures; (2) information the responders believe represent best practices used in making informed decisions on releasing I–131 patients and stand alone or supplemental voluntary patient/licensee guidance acknowledgment forms, if available; (3) an existing set of guidelines that the responder developed or received that provides instructions to released patients; and (4) an existing guidance brochure that the responder believes would be acceptable for nationwide distribution. The responses will form the basis for patient release guidance products developed in response to the NRC’s April 28, 2014, Staff Requirements—COMAMM–14– 0001/COMWDM–14–0001— ‘‘Background and Proposed Direction to NRC Staff to Verify Assumptions Made Concerning Patient Release Guidance.’’ The Commission, based on information from patients and patient advocacy groups, questioned the availability of clear, consistent, patient friendly and timely patient release information and directed the staff to work with a wide variety of stakeholders when developing new guidance products. This information collection effort was developed to gain input from as many stakeholders as possible. The NRC solicitation in the Federal Register is to obtain existing information from a variety of stakeholders. Dated at Rockville, Maryland, this 18th day of June, 2015. For the Nuclear Regulatory Commission. Tremaine Donnell, NRC Clearance Officer, Office of Information Services. [FR Doc. 2015–15391 Filed 6–22–15; 8:45 am] BILLING CODE 7590–01–P VerDate Sep<11>2014 18:39 Jun 22, 2015 Jkt 235001 NUCLEAR REGULATORY COMMISSION [NRC–2015–0147] Information Collection: Environmental Protection Regulations for Domestic Licensing and Related Regulatory Functions Nuclear Regulatory Commission. ACTION: Renewal of existing information collection; request for comment. AGENCY: The U.S. Nuclear Regulatory Commission (NRC) invites public comment on the renewal of Office of Management and Budget (OMB) approval for an existing collection of information. The information collection is entitled, ‘‘Environmental Protection Regulations for Domestic Licensing and Related Regulatory Functions.’’ DATES: Submit comments by August 24, 2015. Comments received after this date will be considered if it is practical to do so, but the Commission is able to ensure consideration only for comments received on or before this date. ADDRESSES: You may submit comments by any of the following methods: • Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC–2015–0147. Address questions about NRC dockets to Carol Gallagher; telephone: 301–287–3422; email: Carol.Gallagher@nrc.gov. For technical questions, contact the individual listed in the FOR FURTHER INFORMATION CONTACT section of this document. • Mail comments to: Tremaine Donnell, Office of Information Services, Mail Stop: T–5 F53, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001. For additional direction on obtaining information and submitting comments, see ‘‘Obtaining Information and Submitting Comments’’ in the SUPPLEMENTARY INFORMATION section of this document. FOR FURTHER INFORMATION CONTACT: Tremaine Donnell, Office of Information Services, U.S. Nuclear Regulatory Commission, Washington, DC 20555– 0001; telephone: 301–415–6258; email: INFOCOLLECTS.Resource@NRC.GOV. SUPPLEMENTARY INFORMATION: SUMMARY: I. Obtaining Information and Submitting Comments A. Obtaining Information Please refer to Docket ID NRC–2015– 0147 when contacting the NRC about the availability of information for this action. You may obtain publicly- PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 35991 available information related to this action by any of the following methods: • Federal rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC–2015–0147. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publiclyavailable documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘ADAMS Public Documents’’ and then select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, 301–415–4737, or by email to pdr.resource@nrc.gov. The supporting statement is available in ADAMS under Accession No. ML15106A720. • NRC’s PDR: You may examine and purchase copies of public documents at the NRC’s PDR, Room O1–F21, One White Flint North, 11555 Rockville Pike, Rockville, Maryland 20852. • NRC’s Clearance Officer: A copy of the collection of information and related instructions may be obtained without charge by contacting NRC’s Clearance Officer, Tremaine Donnell, Office of Information Services, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415– 6258; email: INFOCOLLECTS.Resource@ NRC.GOV. B. Submitting Comments Please include Docket ID NRC–2015– 0147 in your comment submission. The NRC cautions you not to include identifying or contact information in comment submissions that you do not want to be publicly disclosed in your comment submission. The NRC will post all comment submissions at https://www.regulations.gov as well as enter the comment submissions into ADAMS, and the NRC does not routinely edit comment submissions to remove identifying or contact information. If you are requesting or aggregating comments from other persons for submission to the NRC, then you should inform those persons not to include identifying or contact information that they do not want to be publicly disclosed in their comment submission. Your request should state that the NRC does not routinely edit comment submissions to remove such information before making the comment submissions available to the public or entering the comment into ADAMS. E:\FR\FM\23JNN1.SGM 23JNN1

Agencies

[Federal Register Volume 80, Number 120 (Tuesday, June 23, 2015)]
[Notices]
[Pages 35990-35991]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-15391]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2015-0020]


Information Collection: NRC Request for Sodium Iodide I-131 
Treatment and Patient Release Information

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of submission to the Office of Management and Budget; 
request for comment.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) has recently 
submitted a proposed collection of information to the Office of 
Management and Budget (OMB) for review. The information collection is 
entitled, ``NRC Request for Sodium Iodide I-131 Treatment and Patient 
Release Practices.''

DATES: Submit comments by July 23, 2015.

ADDRESSES: Submit comments directly to the OMB reviewer at: Vlad 
Dorjets, Desk Officer, Office of Information and Regulatory Affairs, 
(3150-XXXX), NEOB-10202, Office of Management and Budget, Washington, 
DC 20503; telephone: 202-395-7315, email: Vladik_Dorjets@omb.eop.gov.

FOR FURTHER INFORMATION CONTACT: Tremaine Donnell, NRC Clearance 
Officer, U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001; 
telephone: 301-415-6258; email: INFOCOLLECTS.Resource@nrc.gov.

SUPPLEMENTARY INFORMATION:

I. Obtaining Information and Submitting Comments

A. Obtaining Information

    Please refer to Docket ID NRC 2015-0020 when contacting the NRC 
about the availability of information for this action. You may obtain 
publicly-available information related to this action by any of the 
following methods:
     Federal Rulemaking Web site: Go to https://www.regulations.gov and search for Docket ID NRC 2015-0020. A copy of 
the collection of information and related instructions may be obtained 
without charge by accessing Docket ID NRC 2015-0020 on this Web site.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly-available documents online in the 
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``ADAMS Public Documents'' and 
then select ``Begin Web-based ADAMS Search.'' For problems with ADAMS, 
please contact the NRC's Public Document Room (PDR) reference staff at 
1-800-397-4209, 301-415-4737, or by email to pdr.resource@nrc.gov. The 
supporting statement and Patient Release Federal Register Notice (FRN) 
Soliciting Information is available in ADAMS under Accession No. 
ML15134A123.
     NRC's PDR: You may examine and purchase copies of public 
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555 
Rockville Pike, Rockville, Maryland 20852.
     NRC's Clearance Officer: A copy of the collection of 
information and related instructions may be obtained without charge by 
contacting the NRC's Clearance Officer, Tremaine Donnell, Office of 
Information Services, U.S. Nuclear Regulatory Commission, Washington, 
DC 20555-0001; telephone: 301-415-6258; email: 
INFOCOLLECTS.Resource@NRC.GOV.

B. Submitting Comments

    The NRC cautions you not to include identifying or contact 
information that you do not want to be publicly disclosed in your 
comment submission. The NRC posts all comment submissions at https://www.regulations.gov as well as entering the comment submissions into 
ADAMS. The NRC does not routinely edit comment submissions to remove 
identifying or contact information.
    If you are requesting or aggregating comments from other persons 
for submission to the NRC, then you should inform those persons not to 
include identifying or contact information that they do not want to be 
publicly disclosed in their comment submission. Your request should 
state that the NRC does not routinely edit comment submissions to 
remove such information before making the comment submissions available 
to the public or entering the comment submissions into ADAMS.

II. Background

    Under the provisions of the Paperwork Reduction Act of 1995 (44 
U.S.C. chapter 35), the NRC recently submitted a proposed collection of 
information to OMB for review entitled, ``NRC Request for Sodium Iodide 
I-131 Treatment and Patient Release Practices.'' The NRC hereby informs 
potential respondents that an agency may not conduct or sponsor, and 
that a person is not required to respond to, a collection of 
information unless it displays a currently valid OMB control number.
    The NRC published an FRN with a 60-day comment period on this 
information collection on March 3, 2015; 80 FR 11471, entitled ``NRC 
Request for Sodium Iodide I-131 Treatment and Patient Release 
Practices.''
    1. The title of the information collection: ``NRC Request for 
Sodium Iodide I-131 Treatment and Patient Release Practices.''
    2. OMB approval number: An OMB control number has not yet been 
assigned to this proposed information collection.
    3. Type of submission: New.
    4. The form number if applicable: Not Applicable.
    5. How often the collection is required or requested: Once.
    6. Who will be required or asked to respond: Medical professional 
organizations, physicians, patients, patient advocacy groups, NRC and 
Agreement State medical use licensees, Agreement States, and other 
interested individuals who use, receive, license or have interest in 
the use of I-131 sodium iodide (hereafter referred to as ``I-131'') for 
the treatment of thyroid conditions.

[[Page 35991]]

    7. The estimated number of annual responses: A one-time collection 
estimated to have 1,180 responses (620 medical community + 560 
patients).
    8. The estimated number of annual respondents: 1,180 respondents 
(620 medical community + 560 patients).
    9. An estimate of the total number of hours needed annually to 
comply with the information collection requirement or request: 457.5 
hours (255 medical community + 202.5 patients).
    10. Abstract: The NRC is requesting a one-time information 
collection that will be solicited in an FRN. The FRN will have specific 
I-131 patient release questions associated with: (1) Existing Web sites 
that the responders believe provide access to clear and consistent 
patient information about I-131 treatment processes and procedures; (2) 
information the responders believe represent best practices used in 
making informed decisions on releasing I-131 patients and stand alone 
or supplemental voluntary patient/licensee guidance acknowledgment 
forms, if available; (3) an existing set of guidelines that the 
responder developed or received that provides instructions to released 
patients; and (4) an existing guidance brochure that the responder 
believes would be acceptable for nationwide distribution. The responses 
will form the basis for patient release guidance products developed in 
response to the NRC's April 28, 2014, Staff Requirements--COMAMM-14- 
0001/COMWDM-14-0001--``Background and Proposed Direction to NRC Staff 
to Verify Assumptions Made Concerning Patient Release Guidance.'' The 
Commission, based on information from patients and patient advocacy 
groups, questioned the availability of clear, consistent, patient 
friendly and timely patient release information and directed the staff 
to work with a wide variety of stakeholders when developing new 
guidance products. This information collection effort was developed to 
gain input from as many stakeholders as possible. The NRC solicitation 
in the Federal Register is to obtain existing information from a 
variety of stakeholders.

    Dated at Rockville, Maryland, this 18th day of June, 2015.

    For the Nuclear Regulatory Commission.
Tremaine Donnell,
NRC Clearance Officer, Office of Information Services.
[FR Doc. 2015-15391 Filed 6-22-15; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.